Microbiome Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2305 | Report Format : | Status : Upcoming |

Abstract

Microbiome Therapeutics Market: Overview

The microbiome is a term that is used for the collection of microbes. In the microbiome therapeutics, prebiotics, probiotics, and synbiotics have an influential role in the prevention, diagnosis, and treatment of different types of disease conditions. The factor that favors the microbiome therapeutics is that unlike the drug molecules microbiome therapeutics do not have any side effects since microbiome are already present in the body.

Microbiome Therapeutics Market: Facts

The scientists are making rapid advancements in the study that involves the widespread network of the microbiome and its effect on the human neurology, skin, metabolism, and the immune system. There is evidence that proves that the presence of the dysbiosis in the gut have an effect on an array of conditions such as atopy, cancer, type 2 diabetes, neurological disorders, inflammatory bowel disease, asthma, obesity, and fatty liver disease. The Bristol Myers-Squibb and Enterome entered into the partnership for the development and the discovery of the biomarkers and the microbiome-derived drug targets which will prove useful in the cancer therapeutics.

Microbiome Therapeutics Market: Segmentation

The global market for the microbiome therapeutics is fragmented into its product type, distribution channel, and the application area. On the basis of the product type, the global market is segregated into prebiotics, probiotics, and synbiotics. On the basis of the distribution channel, the market is categorized into drug stores, super and hypermarkets, hospital pharmacies, retail pharmacies, and e-commerce stores. On the basis of the application area, the market is divided into respiratory health, immune conditions, digestive health, oral health, and others.

Microbiome Therapeutics Market: Growth Factors

The primary factors that are driving the microbiome therapeutics market are increase in the problems related to digestion and rise in the drug-related side effects. The therapy can also be used as a treatment for the disease conditions that have no other treatments, as a dietary supplement for improving the overall health, and it is considered as a non-immunogenic as well. The challenges that the market is facing include the high cost of the therapy due to the fact that this therapy is a complex process and needs the extraction of the bacteria in the laboratory. To add on, other factors that restrict the market growth are lack of proper regulations and the microbiomes are heat sensitive.

Microbiome Therapeutics Market: Regional Analysis

The region that is leading in the microbiome therapeutics market is North America which is followed by European regions. The factor that is favoring the growth of the market in the North America is the growing consumption of the dietary supplements. Factor that favors the growth of the market in Europe is the implementation of the less stringent regulations for marketing the probiotic products. In Asia Pacific region, the microbiome therapeutics market is developing at a good pace.

Microbiome Therapeutics Market: Competitive Players

The key market players that are involved in the microbiome therapeutics market include AB-Biotics, AbbVie Inc., Yakult, Ganeden, Pfizer Inc., Johnson and Johnson, Vedanta Biosciences, Dannon, Bayer, Sigma-Tau Pharmaceuticals, and others.

Microbiome Therapeutics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.